Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 14Polycystic Ovary Syndrome 13Leiomyoma 8Menorrhagia 7Prostatic Neoplasms 2Osteoporosis 2Neoplasm Metastasis 2Hyperandrogenism 2Vaginitis 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Pregnancy Complications 1Postmenopausal Vaginal Atrophy 1Neoplasms 1Infertility, Female 1Infertility 1Hot Flashes 1Estrogen Receptor Positive Breast Cancer 1Estrogen Levels Among Breast Cancer Patients 1Endometriosis 1Coronary Disease 1Cardiovascular Diseases 1Breast Carcinoma In Situ 1Atrophic Vaginitis 1Anemia 1Anatomic Stage III Breast Cancer AJCC v8 1Abortion, Spontaneous 1

Interventions

evolocumab 1Vitamin E 1Vitamin D 1Risk Assessment 1Progestins 1Progesterone 1Methods 1Hormone Replacement Therapy 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Electrocardiography 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Coronary Disease × Estradiol × Clear all
NCT01698164 2012-10-02

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

Peking Union Medical College Hospital

Phase 4 Unknown
1,200 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Coronary Disease, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡